DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

St. Jude Medical (STJ) CEO: When it Comes to the Durata Lead, Facts Have Been Very Friendly to Us


1/23/2013 8:23:27 AM

On Wednesday, St. Jude Medical CEO Dan Starks fielded a couple of questions related to its Durata ICD lead on its fourth quarter earnings call, although there were none on a possible recall of the product, despite my expectations. The Durata ICD lead has been troubled by its association with a recalled, previous-generation ICD lead and most recently by a regulatory warning letter which showed that the Food and Drug Administration is concerned about the quality systems in place to design and validate Durata and other products at a plant in California. Matt Taylor, an analyst with Barclays, asked CEO Dan Starks to provide a “current temperature in the field on Durata” and how the company could regain market share. This is how Starks answered the question: The major information that is most compelling to physicians … is the five-year follow-up data, survival data for the Durata product line compared with other products available in the market.

Read at News Release

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->